Vertaling van "regulatory and scientific expertise " (Nederlands → Frans) :

To raise Belgium’s profile even further in the European context, regulatory and scientific expertise needs to carry on being developed, and the quality of the services delivered needs to be monitored and improved continuously.
To raise Belgium’s profile even further in the European context, regulatory and scientific expertise needs to carry on being developed, and the quality of the services delivered needs to be monitored and improved continuously.

This Committee is the body competent for scientific expertise and cooperation between the different FAMHP commissions (see below).
This Committee is the body competent for scientific expertise and cooperation between the different FAMHP commissions (see below).

Omnitrope, the pioneering biosimilar of the recombinant human growth hormone somatropin, has received regulatory approval as the first-ever biosimilar in Japan under the brand name Somatropin BS S.C. This approval paves the way for greater access to high-quality biopharmaceuticals in the world’s second-largest pharmaceuticals market and comes about three months after Japanese authorities published guidelines for a biosimilar regulatory pathway, which is based on similar scientific principles already in place in the European Union.
Omnitrope, biosimilaire pionnier de la somatropine, une hormone de croissance humaine recombinante, a obtenu une autorisation au Japon sous la marque Somatropin BS S.C. Il s’agit du premier biosimilaire à avoir été homologué dans ce pays.

Provision has been made for the organised exchange of information with the national scientific commissions which give final opinions (e.g. evaluation commissions for medicines) and with the representatives on the international scientific or regulatory committees (e.g. CHMP, CVMP, CMD(h), CMD(v), COMP, PDCO).
Provision has been made for the organised exchange of information with the national scientific commissions which give final opinions (e.g. evaluation commissions for medicines) and with the representatives on the international scientific or regulatory committees (e.g. CHMP, CVMP, CMD(h), CMD(v), COMP, PDCO).

financiering van de studie (onderzoekers, geneesmiddelen, personeel, archivering, expertise (klinisch, statistisch, bibliografisch, regulatory, kwaliteitscontrole, )
o Le financement de l'étude (chercheurs, médicaments, personnel, archivage, expertise (clinique, statistique, bibliographique, régulatrice, contrôle de la qualité, .).

●● Providing scientific advice in a regulatory
●● Providing scientific advice in a regulatory

Another significant activity is the provision of national scientific and technical regulatory advice.
Another significant activity is the provision of national scientific and technical regulatory advice.

Workshop on the Technical/Scientific and Regulatory Issues on the safety of tattoos, Body Piercing and Related Practices; European Commission, Ispra,VA,Italy 2003; 89-92.
Workshop on the Technical/Scientific and Regulatory Issues on the safety of tattoos, Body Piercing and Related Practices; European Commission, Ispra, VA, Italy 2003; 89-92.

Workshop on the Technical/Scientific and Regulatory Issues on the safety of tattoos, Body Piercing and Related Practices. European Commission, Ispra, VA, Italy 21-37.
Workshop on the Technical/Scientific and Regulatory Issues on the safety of tattoos, Body Piercing and Related Practices; European Commission, Ispra, VA, Italy 21-37.

Encouraging clinical trials and the inherent evaluation of applications for these trials, as well as the creation of a scientific subgroup for oncology, means that the FAMHP will need to have the necessary autonomy to attract the essential expertise for this relatively complex domain from the point of concept of innovative medicines.
Encouraging clinical trials and the inherent evaluation of applications for these trials, as well as the creation of a scientific subgroup for oncology, means that the FAMHP will need to have the necessary autonomy to attract the essential expertise for this relatively complex domain from the point of concept of innovative medicines.